Sign in
LGNXZ Stock Price, Chart, Stats & News
Ligand Pharmaceuticals, Inc.
Save
Ligand Pharmaceuticals, Inc. (LGNXZ) does not currently pay a dividend.
40,082
Market cap
–
Current P/E
–
Forward P/E
LGNXZ chart
About
Health care
Sector
Medical - Pharmaceuticals
Industry
Ligand Pharmaceuticals, Inc. operates as a biopharmaceutical enterprise, primarily engaged in sourcing and advancing innovative technologies. These technologies are instrumental in assisting other pharmaceutical businesses with the identification and progression of new therapeutic solutions. The company's portfolio includes medications such as evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV.
Similar securities
Based on sector and market capitalization
Report issue